Anti-Cancer N-Heterocyclic Carbene Complexes of Gold(III), Gold(I) and Platinum(II)
Thiol "Switch-on" Fluorescent Probes, Thioredoxin Reductase Inhibitors and Endoplasmic Reticulum Targeting Agents
(Sprache: Englisch)
This thesis focuses on the development of gold- and non-classical platinum-based anti-cancer agents that display distinctively different anti-cancer mechanisms compared to the commonly used cisplatin. These metal complexes contain N-heterocyclic carbene...
Jetzt vorbestellen
versandkostenfrei
Buch (Gebunden)
Fr. 130.90
inkl. MwSt.
- Kreditkarte, Paypal, Rechnungskauf
- 30 Tage Widerrufsrecht
Produktdetails
Produktinformationen zu „Anti-Cancer N-Heterocyclic Carbene Complexes of Gold(III), Gold(I) and Platinum(II) “
Klappentext zu „Anti-Cancer N-Heterocyclic Carbene Complexes of Gold(III), Gold(I) and Platinum(II) “
This thesis focuses on the development of gold- and non-classical platinum-based anti-cancer agents that display distinctively different anti-cancer mechanisms compared to the commonly used cisplatin. These metal complexes contain N-heterocyclic carbene (NHC) ligands which are able to form strong M-C(NHC) bonds, conferring high stability and favorable lipophilicity, reactivity and binding specificity of metal complexes on biomolecules. The author demonstrates significant advances made in anti-cancer gold(III), gold(I) and platinum(II) complexes. Detailed chemical synthesis, in vitro and/or in vivo anti-cancer activities are clearly presented including: (i) a class of Au(III) complexes containing a highly fluorescent N^N^N ligand and NHC ligand that simultaneously act as fluorescent thiol "switch-on" probes and anti-cancer agents; (ii) a dinuclear gold(I) complex with a mixed diphosphine and bis(NHC) ligand displaying favorable stability and showing significant inhibition of tumor growth in two independent mice models with no observable side effects; and (iii) a panel of stable luminescent cyclometalated platinum(II) complexes exhibiting high specificity to localize to the endoplasmic reticulum (ER) domain, inducing ER stress and cell apoptosis. These works highlight the clinical potential that gold and platinum complexes offer for cancer treatment.Inhaltsverzeichnis zu „Anti-Cancer N-Heterocyclic Carbene Complexes of Gold(III), Gold(I) and Platinum(II) “
Introduction.- Experimental Section.- Gold(III) ComplexesContaining N-Heterocyclic Carbene Ligand Serve as Dual FluorescentThiol "Switch-on" Probe and Anti-Cancer Agent.- A Binuclear Gold(I) Complexwith Mixed Bridging Diphosphine and Bis(N-Heterocyclic Carbene) Ligands ShowsFavorable Thiol Reactivity and Effectively Inhibits Tumor Growth andAngiogenesis in Vivo.- Luminescent Organoplatinum(II)Complexes Containing Bis(N-Heterocyclic Carbene) Ligands Selectively TargetEndoplasmic Reticulum and Induce Potent Phototoxicity.- Summary and Evaluation.
Autoren-Porträt von Taotao Zou
Bibliographische Angaben
- Autor: Taotao Zou
- 2016, 1st ed. 2016, XIII, 164 Seiten, 79 farbige Abbildungen, Masse: 16 x 24,1 cm, Gebunden, Englisch
- Verlag: Springer, Berlin
- ISBN-10: 9811006563
- ISBN-13: 9789811006562
- Erscheinungsdatum: 02.03.2016
Sprache:
Englisch
Kommentar zu "Anti-Cancer N-Heterocyclic Carbene Complexes of Gold(III), Gold(I) and Platinum(II)"
0 Gebrauchte Artikel zu „Anti-Cancer N-Heterocyclic Carbene Complexes of Gold(III), Gold(I) and Platinum(II)“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Anti-Cancer N-Heterocyclic Carbene Complexes of Gold(III), Gold(I) and Platinum(II)".
Kommentar verfassen